Aikyam Capital sold 1,50,000 shares of Speciality Medicines Limited for ₹2.02 Cr at ₹134.43 apiece in a bulk deal.
A pharmaceutical company engaged in marketing and distribution of speciality finished formulations across India. Incorporated in 2021, the company focuses on niche therapeutic areas and builds its business through strategic partnerships with established pharmaceutical manufacturers. Speciality Medi operates as a specialized distribution and marketing platform serving hospitals, clinics, and retail pharmacies with medicines targeting specific disease segments and patient populations in the Indian pharmaceutical sector.
Mumbai-based investment platform founded in 2022 by ex-banker Nilesh Choudhary. Aikyam spans investment banking, stressed-asset management, institutional broking and PMS, taking concentrated mid and smallcap positions in listed Indian equities.